China Approves GSK's Two-dose Vaccine Cervarix For Girls Aged 9-14

GlaxoSmithKline PLC (GSK) on Friday said China's National Medical Products Administration (NMPA) has approved a two-dose regimen of its Human Papillomavirus (HPV) vaccine, Cervarix for girls aged 9 to 14 years.

Two-dose vaccine schedule for Cervarix is approved in China for the prevention of cervical cancer, cervical intraepithelial neoplasia and adenocarcinoma in situ causally related to oncogenic Human Papillomavirus (HPV) types 16 and 18.

With this approval, Cervarix is the first imported two-dose HPV vaccine for this age group in mainland China, Glaxo said.

The two-dose regimen vaccine is approved in more than 100 countries including the European Union, Asia, Africa, and Latin America.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
Follow RTT